Several high-profile unicorns are returning to public markets—this time at valuations that reflect today’s market, not 2021 exuberance. Circle, Omada Health, and Hinge Health are among the companies recently going public below their last private valuations, a trend Axios highlights as a sign of “accepting reality.”
It’s more than that. These moves represent a recalibration that could benefit the entire venture capital ecosystem—especially for startups preparing to raise capital.
A Healthier Liquidity Environment
When companies go public—regardless of valuation—they convert private equity into liquid capital. For the first time in years, limited partners and venture funds are starting to see distributions again.
That matters. Most venture firms operate on a 10-year fund cycle, but without exits, even well-performing portfolios become bottlenecks. A functioning IPO market, even at compressed valuations, unblocks that capital.
What This Means for Startups and Capital Flows
This return of liquidity has ripple effects across the funding stack:
- Recycled LP Capital: As VCs return capital to their LPs, they unlock capacity for new funds. That flows down to more check-writing activity at the early and growth stages.
- PE-Led Growth Deals: Private equity funds, which often co-invest or acquire maturing venture-backed businesses, benefit from a clearer path to exit. That boosts confidence in crossover strategies.
- Valuation Realism: Public pricing helps reset expectations across stages. Startups no longer have to negotiate against 2021 comps that aren’t grounded in today’s market reality.
- Increased Deal Velocity: With exits back on the table, GPs are under less pressure to sit on dry powder. That accelerates decision-making and increases competitiveness in quality deals.
Signals for Founders
For founders raising capital in 2025, this shift is encouraging. It doesn’t guarantee easier term sheets—but it does mean the capital cycle is beginning to move again. Investors now have more flexibility and fewer legacy price anchors.
Importantly, we’re seeing a return to fundamentals-driven investing: unit economics, execution quality, and market timing are taking precedence over inflated projections.
Supporting Founders Through Market Transitions
At Fidelman & Co., we work closely with founders navigating capital raises in shifting markets. Our advisory and fundraise-as-a-service model is tailored to help high-growth companies run institutional processes from day one—especially in moments like this, when clarity and positioning matter most.
If you’re preparing for a raise or reevaluating your strategy post-2021, we’re here to help.
Contact Fidelman & Co. to explore how we support capital formation across venture, growth, and crossover stages.
